CompletedPhase 2NCT02295566

RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital Southampton NHS Foundation Trust
Principal Investigator
Saul Faust
University Hopsital Southampton NHS Foundation Trust
Intervention
Nitric Oxide(drug)
Enrollment
12 enrolled
Eligibility
12 years · All sexes
Timeline
2011 – 2013

Study locations (1)

Collaborators

University of Southampton

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02295566 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis →

← Back to all trials